The Société Francophone du Diabète congress was held in Toulouse from March 19 to 24. The Sanofi Group welcomed Montpellier-based medtech Diappymed to its stand. Diappymed is preparing to roll out a new personalized insulin dosage application for insulin-dependent people, and is working on obtaining social security reimbursement for its device.
Treatment of insulin-dependent diabetes: DiappyMed aims for social security reimbursement
